Medifron DBT Co. Ltd (065650) — Cash Flow-to-Debt Ratio
Medifron DBT Co. Ltd (065650) has a Cash Flow-to-Debt Ratio of -0.15x as of September 2025, meaning its operating cash flow of ₩-12.73 Billion could theoretically repay 0% of its total liabilities (₩86.61 Billion) in one year. See 065650 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Medifron DBT Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Medifron DBT Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see 065650 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Medifron DBT Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for Medifron DBT Co. Ltd. Check 065650 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.11x | ₩-4.54 Billion | ₩42.92 Billion | ▲ +6.6% |
| 2023 | -0.11x | ₩-2.14 Billion | ₩18.89 Billion | ▲ +4.2% |
| 2022 | -0.12x | ₩-2.91 Billion | ₩24.66 Billion | ▲ +46.5% |
| 2021 | -0.22x | ₩-1.50 Billion | ₩6.81 Billion | ▼ -155.3% |
| 2020 | -0.09x | ₩-1.67 Billion | ₩19.36 Billion | ▲ +96.4% |
| 2019 | -2.42x | ₩-4.28 Billion | ₩1.77 Billion | ▼ -574.2% |
| 2018 | -0.36x | ₩-852.48 Million | ₩2.37 Billion | ▲ +54.2% |
| 2017 | -0.78x | ₩-1.17 Billion | ₩1.49 Billion | ▼ -48.2% |
| 2016 | -0.53x | ₩-1.15 Billion | ₩2.18 Billion | ▼ -2085.2% |
| 2015 | -0.02x | ₩-170.27 Million | ₩7.04 Billion | ▼ -5408.5% |
| 2014 | 0.00x | ₩701.96K | ₩1.54 Billion | — |